Esperion Therapeutics Stock Statistic Functions Linear Regression Angle

ESPR Stock  USD 2.69  -0.01  -0.37%   
Use the statistic functions workspace to apply Linear Regression Angle function and other studies to Esperion Therapeutics. This view tracks statistical functions describing dispersion and variability to support structured performance interpretation without implying advice.Enter Time Period to generate the indicator output.

Execute Function
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Angle indicator plots the angel of the trend line for each Esperion Therapeutics data point.

Esperion Therapeutics Technical Analysis Modules

Most technical analysis of Esperion Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Esperion from various momentum indicators to cycle indicators. When you analyze Esperion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Esperion Therapeutics Inc

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Esperion Theraptc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 218 people. A high-level view of Esperion Therapeutics emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/B of 98.42, profit margin of -34.84%. Esperion Therapeutics has market cap of 645.47 M, ROE of -2.61%.

Methodology

Unless otherwise specified, financial data for Esperion Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Esperion (USA Stocks:ESPR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Esperion Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Esperion Therapeutics is covered by 7 analysts. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include J.P. Morgan, Stifel, BMO Capital Markets, Oppenheimer & Co., Citigroup, RBC Capital Markets, among others. Updates may occur throughout the day.


Become your own money manager

Tracking Esperion Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested over 200 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Impulse Idea
Impulse
Invested over 200 shares
Advertising Idea
Advertising
Invested few shares
Blockchain Idea
Blockchain
Invested few shares

Additional Tools for Esperion Stock Analysis

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon